Trials / Completed
CompletedNCT05783336
Stepping Stones and Creating Futures Plus Pilot
An Inter-disciplinary Approach to Understanding and Intervening on Contextual Factors That Shape HIV-risk for Young Women and Men in South Africa: Phase 2 - the Feasibility, Acceptability and Potential Effect Size of a Pilot Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 323 (actual)
- Sponsor
- University of Exeter · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The goal of this randomised controlled clinical trial is to test the Stepping Stones and Creating Futures Plus (SSCF+) intervention, in young (18-25 years) people living in urban informal settlements in Durban and rural communities in KwaZulu-Natal, South Africa. The main questions it aims to answer are: * Is the intervention acceptable and feasible * What is the potential effect size on key outcomes of intimate partner violence Participants will be randomised (1:1) to compare SSCF+ and a control arm to see if there are differences between the two on intimate partner violence.
Detailed description
Intimate partner violence is very common in South Africa, particularly urban informal settlements. We have co-developed an intervention, called Stepping Stones and Creating Futures Plus (SSCF+), which will be evaluated in women and men aged 18-25 years living in KwaZulu-Natal, South Africa. This is a pilot randomised controlled trial and as such there is focus on understanding whether the intervention is acceptable (to participants), feasible to deliver, and the potential effect sizes we may see in a full trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Stepping Stones and Creating Futures Plus (SSCF+) | Group-based intervention delivered to small friendship networks, by a facilitator. |
Timeline
- Start date
- 2023-05-24
- Primary completion
- 2023-11-28
- Completion
- 2023-11-28
- First posted
- 2023-03-24
- Last updated
- 2024-05-08
Locations
1 site across 1 country: South Africa
Source: ClinicalTrials.gov record NCT05783336. Inclusion in this directory is not an endorsement.